Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Oncology|August 29, 2024
Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers: A Systematic ReviewSjoerd J F Hermans, Niek G van der Maas, Yvette van Norden, et al.
Blood Cancer Journal|March 28, 2024
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trialNiek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, et al.
Eclinicalmedicine|November 17, 2025
Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trialMaarten R Seefat, Niek G van der Maas, Kazem Nasserinejad, et al.
Haematologica|October 2, 2025
The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncologyAnna J T Smit, Niek G Van der Maas, Bronno Van der Holt, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Pageof 1